<?xml version='1.0' encoding='UTF-8'?>
<uniprot xmlns="http://uniprot.org/uniprot" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://uniprot.org/uniprot http://www.uniprot.org/support/docs/uniprot.xsd">
<entry dataset="Swiss-Prot" created="2005-02-01" modified="2017-09-27" version="132">
<accession>Q6Q788</accession>
<accession>B0YIV9</accession>
<accession>Q3MIK6</accession>
<accession>Q6UWK9</accession>
<accession>Q9UBJ3</accession>
<name>APOA5_HUMAN</name>
<protein>
<recommendedName>
<fullName>Apolipoprotein A-V</fullName>
<shortName>Apo-AV</shortName>
<shortName>ApoA-V</shortName>
</recommendedName>
<alternativeName>
<fullName>Apolipoprotein A5</fullName>
</alternativeName>
<alternativeName>
<fullName>Regeneration-associated protein 3</fullName>
</alternativeName>
</protein>
<gene>
<name type="primary">APOA5</name>
<name type="synonym">RAP3</name>
<name type="ORF">UNQ411/PRO773</name>
</gene>
<organism>
<name type="scientific">Homo sapiens</name>
<name type="common">Human</name>
<dbReference type="NCBI Taxonomy" id="9606"/>
<lineage>
<taxon>Eukaryota</taxon>
<taxon>Metazoa</taxon>
<taxon>Chordata</taxon>
<taxon>Craniata</taxon>
<taxon>Vertebrata</taxon>
<taxon>Euteleostomi</taxon>
<taxon>Mammalia</taxon>
<taxon>Eutheria</taxon>
<taxon>Euarchontoglires</taxon>
<taxon>Primates</taxon>
<taxon>Haplorrhini</taxon>
<taxon>Catarrhini</taxon>
<taxon>Hominidae</taxon>
<taxon>Homo</taxon>
</lineage>
</organism>
<reference key="1">
<citation type="journal article" date="2001" name="J. Biol. Chem." volume="276" first="44512" last="44520">
<title>Apolipoprotein A-V. A novel apolipoprotein associated with an early phase of liver regeneration.</title>
<authorList>
<person name="van Der Vliet H.N."/>
<person name="Sammels M.G."/>
<person name="Leegwater A.C.J."/>
<person name="Levels J.H.M."/>
<person name="Reitsma P.H."/>
<person name="Boers W."/>
<person name="Chamuleau R.A.F.M."/>
</authorList>
<dbReference type="PubMed" id="11577099"/>
<dbReference type="DOI" id="10.1074/jbc.M106888200"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [MRNA]</scope>
<scope>TISSUE SPECIFICITY</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="2">
<citation type="journal article" date="2004" name="Hum. Genet." volume="115" first="36" last="56">
<title>The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.</title>
<authorList>
<person name="Fullerton S.M."/>
<person name="Buchanan A.V."/>
<person name="Sonpar V.A."/>
<person name="Taylor S.L."/>
<person name="Smith J.D."/>
<person name="Carlson C.S."/>
<person name="Salomaa V."/>
<person name="Stengaard J.H."/>
<person name="Boerwinkle E."/>
<person name="Clark A.G."/>
<person name="Nickerson D.A."/>
<person name="Weiss K.M."/>
</authorList>
<dbReference type="PubMed" id="15108119"/>
<dbReference type="DOI" id="10.1007/s00439-004-1106-x"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
<scope>VARIANTS TRP-19 AND MET-153</scope>
</reference>
<reference key="3">
<citation type="journal article" date="2003" name="Genome Res." volume="13" first="2265" last="2270">
<title>The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment.</title>
<authorList>
<person name="Clark H.F."/>
<person name="Gurney A.L."/>
<person name="Abaya E."/>
<person name="Baker K."/>
<person name="Baldwin D.T."/>
<person name="Brush J."/>
<person name="Chen J."/>
<person name="Chow B."/>
<person name="Chui C."/>
<person name="Crowley C."/>
<person name="Currell B."/>
<person name="Deuel B."/>
<person name="Dowd P."/>
<person name="Eaton D."/>
<person name="Foster J.S."/>
<person name="Grimaldi C."/>
<person name="Gu Q."/>
<person name="Hass P.E."/>
<person name="Heldens S."/>
<person name="Huang A."/>
<person name="Kim H.S."/>
<person name="Klimowski L."/>
<person name="Jin Y."/>
<person name="Johnson S."/>
<person name="Lee J."/>
<person name="Lewis L."/>
<person name="Liao D."/>
<person name="Mark M.R."/>
<person name="Robbie E."/>
<person name="Sanchez C."/>
<person name="Schoenfeld J."/>
<person name="Seshagiri S."/>
<person name="Simmons L."/>
<person name="Singh J."/>
<person name="Smith V."/>
<person name="Stinson J."/>
<person name="Vagts A."/>
<person name="Vandlen R.L."/>
<person name="Watanabe C."/>
<person name="Wieand D."/>
<person name="Woods K."/>
<person name="Xie M.-H."/>
<person name="Yansura D.G."/>
<person name="Yi S."/>
<person name="Yu G."/>
<person name="Yuan J."/>
<person name="Zhang M."/>
<person name="Zhang Z."/>
<person name="Goddard A.D."/>
<person name="Wood W.I."/>
<person name="Godowski P.J."/>
<person name="Gray A.M."/>
</authorList>
<dbReference type="PubMed" id="12975309"/>
<dbReference type="DOI" id="10.1101/gr.1293003"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
</reference>
<reference key="4">
<citation type="submission" date="2007-02" db="EMBL/GenBank/DDBJ databases">
<authorList>
<consortium name="NHLBI resequencing and genotyping service (RS&amp;G)"/>
</authorList>
</citation>
<scope>NUCLEOTIDE SEQUENCE [GENOMIC DNA]</scope>
</reference>
<reference key="5">
<citation type="journal article" date="2004" name="Genome Res." volume="14" first="2121" last="2127">
<title>The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC).</title>
<authorList>
<consortium name="The MGC Project Team"/>
</authorList>
<dbReference type="PubMed" id="15489334"/>
<dbReference type="DOI" id="10.1101/gr.2596504"/>
</citation>
<scope>NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="6">
<citation type="journal article" date="2001" name="Science" volume="294" first="169" last="173">
<title>An apolipoprotein influencing triglycerides in humans and mice revealed by comparative sequencing.</title>
<authorList>
<person name="Pennacchio L.A."/>
<person name="Olivier M."/>
<person name="Hubacek J.A."/>
<person name="Cohen J.C."/>
<person name="Cox D.R."/>
<person name="Fruchart J.-C."/>
<person name="Krauss R.M."/>
<person name="Rubin E.M."/>
</authorList>
<dbReference type="PubMed" id="11588264"/>
<dbReference type="DOI" id="10.1126/science.1064852"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="7">
<citation type="journal article" date="2003" name="Biochemistry" volume="42" first="9416" last="9423">
<title>Structure-function studies of human apolipoprotein A-V: a regulator of plasma lipid homeostasis.</title>
<authorList>
<person name="Beckstead J.A."/>
<person name="Oda M.N."/>
<person name="Martin D.D.O."/>
<person name="Forte T.M."/>
<person name="Bielicki J.K."/>
<person name="Berger T."/>
<person name="Luty R."/>
<person name="Kay C.M."/>
<person name="Ryan R.O."/>
</authorList>
<dbReference type="PubMed" id="12899628"/>
<dbReference type="DOI" id="10.1021/bi034509t"/>
</citation>
<scope>FUNCTION</scope>
</reference>
<reference key="8">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="25468" last="25480">
<title>The human apolipoprotein AV gene is regulated by peroxisome proliferator-activated receptor-alpha and contains a novel farnesoid X-activated receptor response element.</title>
<authorList>
<person name="Prieur X."/>
<person name="Coste H."/>
<person name="Rodriguez J.C."/>
</authorList>
<dbReference type="PubMed" id="12709436"/>
<dbReference type="DOI" id="10.1074/jbc.M301302200"/>
</citation>
<scope>INDUCTION</scope>
</reference>
<reference key="9">
<citation type="journal article" date="2003" name="J. Biol. Chem." volume="278" first="34438" last="34444">
<title>Structure and interfacial properties of human apolipoprotein A-V.</title>
<authorList>
<person name="Weinberg R.B."/>
<person name="Cook V.R."/>
<person name="Beckstead J.A."/>
<person name="Martin D.D.O."/>
<person name="Gallagher J.W."/>
<person name="Shelness G.S."/>
<person name="Ryan R.O."/>
</authorList>
<dbReference type="PubMed" id="12810715"/>
<dbReference type="DOI" id="10.1074/jbc.M303784200"/>
</citation>
<scope>SUBCELLULAR LOCATION</scope>
</reference>
<reference key="10">
<citation type="journal article" date="2005" name="Clin. Chem." volume="51" first="351" last="359">
<title>The novel apolipoprotein A5 is present in human serum, is associated with VLDL, HDL, and chylomicrons, and circulates at very low concentrations compared with other apolipoproteins.</title>
<authorList>
<person name="O'Brien P.J."/>
<person name="Alborn W.E."/>
<person name="Sloan J.H."/>
<person name="Ulmer M."/>
<person name="Boodhoo A."/>
<person name="Knierman M.D."/>
<person name="Schultze A.E."/>
<person name="Konrad R.J."/>
</authorList>
<dbReference type="PubMed" id="15528295"/>
<dbReference type="DOI" id="10.1373/clinchem.2004.040824"/>
</citation>
<scope>FUNCTION</scope>
<scope>TISSUE SPECIFICITY</scope>
</reference>
<reference key="11">
<citation type="journal article" date="2007" name="Biochim. Biophys. Acta" volume="1771" first="1464" last="1468">
<title>Normal binding of lipoprotein lipase, chylomicrons, and apo-AV to GPIHBP1 containing a G56R amino acid substitution.</title>
<authorList>
<person name="Gin P."/>
<person name="Beigneux A.P."/>
<person name="Davies B."/>
<person name="Young M.F."/>
<person name="Ryan R.O."/>
<person name="Bensadoun A."/>
<person name="Fong L.G."/>
<person name="Young S.G."/>
</authorList>
<dbReference type="PubMed" id="17997385"/>
<dbReference type="DOI" id="10.1016/j.bbalip.2007.10.005"/>
</citation>
<scope>INTERACTION WITH GPIHBP1</scope>
</reference>
<reference key="12">
<citation type="journal article" date="2014" name="J. Proteomics" volume="96" first="253" last="262">
<title>An enzyme assisted RP-RPLC approach for in-depth analysis of human liver phosphoproteome.</title>
<authorList>
<person name="Bian Y."/>
<person name="Song C."/>
<person name="Cheng K."/>
<person name="Dong M."/>
<person name="Wang F."/>
<person name="Huang J."/>
<person name="Sun D."/>
<person name="Wang L."/>
<person name="Ye M."/>
<person name="Zou H."/>
</authorList>
<dbReference type="PubMed" id="24275569"/>
<dbReference type="DOI" id="10.1016/j.jprot.2013.11.014"/>
</citation>
<scope>PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-59</scope>
<scope>IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]</scope>
<source>
<tissue>Liver</tissue>
</source>
</reference>
<reference key="13">
<citation type="journal article" date="2015" name="Cell" volume="161" first="1619" last="1632">
<title>A single kinase generates the majority of the secreted phosphoproteome.</title>
<authorList>
<person name="Tagliabracci V.S."/>
<person name="Wiley S.E."/>
<person name="Guo X."/>
<person name="Kinch L.N."/>
<person name="Durrant E."/>
<person name="Wen J."/>
<person name="Xiao J."/>
<person name="Cui J."/>
<person name="Nguyen K.B."/>
<person name="Engel J.L."/>
<person name="Coon J.J."/>
<person name="Grishin N."/>
<person name="Pinna L.A."/>
<person name="Pagliarini D.J."/>
<person name="Dixon J.E."/>
</authorList>
<dbReference type="PubMed" id="26091039"/>
<dbReference type="DOI" id="10.1016/j.cell.2015.05.028"/>
</citation>
<scope>PHOSPHORYLATION AT THR-55</scope>
</reference>
<reference key="14">
<citation type="journal article" date="2002" name="Hum. Mol. Genet." volume="11" first="3031" last="3038">
<title>Two independent apolipoprotein A5 haplotypes influence human plasma triglyceride levels.</title>
<authorList>
<person name="Pennacchio L.A."/>
<person name="Olivier M."/>
<person name="Hubacek J.A."/>
<person name="Krauss R.M."/>
<person name="Rubin E.M."/>
<person name="Cohen J.C."/>
</authorList>
<dbReference type="PubMed" id="12417524"/>
<dbReference type="DOI" id="10.1093/hmg/11.24.3031"/>
</citation>
<scope>POLYMORPHISM</scope>
<scope>VARIANT TRP-19</scope>
</reference>
<reference key="15">
<citation type="journal article" date="2003" name="J. Med. Genet." volume="40" first="E105" last="E105">
<title>Ser19Trp polymorphism within the apolipoprotein AV gene in hypertriglyceridaemic people.</title>
<authorList>
<person name="Vrablik M."/>
<person name="Horinek A."/>
<person name="Ceska R."/>
<person name="Adamkova V."/>
<person name="Poledne R."/>
<person name="Hubacek J.A."/>
</authorList>
<dbReference type="PubMed" id="12920097"/>
<dbReference type="DOI" id="10.1136/jmg.40.8.e105"/>
</citation>
<scope>VARIANT TRP-19</scope>
</reference>
<reference key="16">
<citation type="journal article" date="2003" name="Hum. Mol. Genet." volume="12" first="2533" last="2539">
<title>A novel genetic variant in the apolipoprotein A5 gene is associated with hypertriglyceridemia.</title>
<authorList>
<person name="Kao J.-T."/>
<person name="Wen H.-C."/>
<person name="Chien K.-L."/>
<person name="Hsu H.-C."/>
<person name="Lin S.-W."/>
</authorList>
<dbReference type="PubMed" id="12915450"/>
<dbReference type="DOI" id="10.1093/hmg/ddg255"/>
</citation>
<scope>VARIANT CYS-185</scope>
</reference>
<reference key="17">
<citation type="journal article" date="2005" name="J. Clin. Invest." volume="115" first="2862" last="2869">
<title>Apoa5 Q139X truncation predisposes to late-onset hyperchylomicronemia due to lipoprotein lipase impairment.</title>
<authorList>
<person name="Marcais C."/>
<person name="Verges B."/>
<person name="Charriere S."/>
<person name="Pruneta V."/>
<person name="Merlin M."/>
<person name="Billon S."/>
<person name="Perrot L."/>
<person name="Drai J."/>
<person name="Sassolas A."/>
<person name="Pennacchio L.A."/>
<person name="Fruchart-Najib J."/>
<person name="Fruchart J.C."/>
<person name="Durlach V."/>
<person name="Moulin P."/>
</authorList>
<dbReference type="PubMed" id="16200213"/>
<dbReference type="DOI" id="10.1172/JCI24471"/>
</citation>
<scope>INVOLVEMENT IN HLPP5</scope>
</reference>
<comment type="function">
<text evidence="2 5 9 13">Minor apolipoprotein mainly associated with HDL and to a lesser extent with VLDL. May also be associated with chylomicrons. Important determinant of plasma triglyceride (TG) levels by both being a potent stimulator of apo-CII lipoprotein lipase (LPL) TG hydrolysis and a inhibitor of the hepatic VLDL-TG production rate (without affecting the VLDL-apoB production rate) (By similarity). Activates poorly lecithin:cholesterol acyltransferase (LCAT) and does not enhance efflux of cholesterol from macrophages.</text>
</comment>
<comment type="subunit">
<text evidence="15">Interacts with GPIHBP1.</text>
</comment>
<comment type="subcellular location">
<subcellularLocation>
<location evidence="8">Secreted</location>
</subcellularLocation>
</comment>
<comment type="tissue specificity">
<text evidence="4 5 13">Liver and plasma.</text>
</comment>
<comment type="induction">
<text evidence="7">Up-regulated by PPARA agonists, which are used clinically to lower serum TG (such as fibrates).</text>
</comment>
<comment type="PTM">
<text evidence="16">Phosphorylated by FAM20C in the extracellular medium.</text>
</comment>
<comment type="polymorphism">
<text evidence="6">Three common alleles are known: allele APOA5*1, APOA5*2 and APOA5*3. The APOA5*2 haplotype, which consists of 3 non-coding SNPs, is present in approximately 16% of Caucasians and is associated with increased plasma triglyceride concentrations. APOA5*3 haplotype is defined by the rare Ser-19-Trp substitution. Together, the APOA5*2 and APOA5*3 haplotypes are found in 25 to 50% of African Americans, Hispanics, and Caucasians.</text>
</comment>
<comment type="disease">
<disease id="DI-01586">
<name>Hypertriglyceridemia, familial</name>
<acronym>FHTR</acronym>
<description>A common inherited disorder in which the concentration of very low density lipoprotein (VLDL) is elevated in the plasma. This leads to increased risk of heart disease, obesity, and pancreatitis.</description>
<dbReference type="MIM" id="145750"/>
</disease>
<text>Disease susceptibility is associated with variations affecting the gene represented in this entry.</text>
</comment>
<comment type="disease" evidence="14">
<disease id="DI-01772">
<name>Hyperlipoproteinemia 5</name>
<acronym>HLPP5</acronym>
<description>Characterized by increased amounts of chylomicrons and very low density lipoprotein (VLDL) and decreased low density lipoprotein (LDL) and high density lipoprotein (HDL) in the plasma after a fast. Numerous conditions cause this phenotype, including insulin-dependent diabetes mellitus, contraceptive steroids, alcohol abuse, and glycogen storage disease type 1A (GSD1A).</description>
<dbReference type="MIM" id="144650"/>
</disease>
<text>The disease is caused by mutations affecting the gene represented in this entry.</text>
</comment>
<comment type="miscellaneous">
<text>Induced in early phase of liver regeneration.</text>
</comment>
<comment type="similarity">
<text evidence="17">Belongs to the apolipoprotein A1/A4/E family.</text>
</comment>
<comment type="caution">
<text evidence="17">It is uncertain whether Met-1 or Met-4 is the initiator.</text>
</comment>
<comment type="sequence caution" evidence="17">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAF25661" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="17">
<conflict type="erroneous initiation">
<sequence resource="EMBL-CDS" id="AAF25662" version="1"/>
</conflict>
</comment>
<comment type="sequence caution" evidence="17">
<conflict type="erroneous termination">
<sequence resource="EMBL-CDS" id="AAQ89109" version="1"/>
</conflict>
<location>
<position position="275"/>
</location>
<text>Translated as Gln.</text>
</comment>
<dbReference type="EMBL" id="AF202889">
<property type="protein sequence ID" value="AAF25661.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AF202890">
<property type="protein sequence ID" value="AAF25662.1"/>
<property type="status" value="ALT_INIT"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="AY555191">
<property type="protein sequence ID" value="AAS68229.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY422949">
<property type="protein sequence ID" value="AAQ91808.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="AY358749">
<property type="protein sequence ID" value="AAQ89109.1"/>
<property type="status" value="ALT_SEQ"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444949">
<property type="protein sequence ID" value="ACA05937.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="EF444949">
<property type="protein sequence ID" value="ACA05938.1"/>
<property type="molecule type" value="Genomic_DNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101787">
<property type="protein sequence ID" value="AAI01788.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="EMBL" id="BC101789">
<property type="protein sequence ID" value="AAI01790.1"/>
<property type="molecule type" value="mRNA"/>
</dbReference>
<dbReference type="CCDS" id="CCDS8376.2"/>
<dbReference type="RefSeq" id="NP_001160070.1">
<property type="nucleotide sequence ID" value="NM_001166598.1"/>
</dbReference>
<dbReference type="RefSeq" id="NP_443200.2">
<property type="nucleotide sequence ID" value="NM_052968.4"/>
</dbReference>
<dbReference type="RefSeq" id="XP_016872658.1">
<property type="nucleotide sequence ID" value="XM_017017169.1"/>
</dbReference>
<dbReference type="UniGene" id="Hs.283923"/>
<dbReference type="ProteinModelPortal" id="Q6Q788"/>
<dbReference type="SMR" id="Q6Q788"/>
<dbReference type="BioGrid" id="125518">
<property type="interactions" value="3"/>
</dbReference>
<dbReference type="IntAct" id="Q6Q788">
<property type="interactions" value="10"/>
</dbReference>
<dbReference type="STRING" id="9606.ENSP00000227665"/>
<dbReference type="iPTMnet" id="Q6Q788"/>
<dbReference type="PhosphoSitePlus" id="Q6Q788"/>
<dbReference type="BioMuta" id="APOA5"/>
<dbReference type="DMDM" id="60391728"/>
<dbReference type="MaxQB" id="Q6Q788"/>
<dbReference type="PaxDb" id="Q6Q788"/>
<dbReference type="PeptideAtlas" id="Q6Q788"/>
<dbReference type="PRIDE" id="Q6Q788"/>
<dbReference type="Ensembl" id="ENST00000227665">
<property type="protein sequence ID" value="ENSP00000227665"/>
<property type="gene ID" value="ENSG00000110243"/>
</dbReference>
<dbReference type="Ensembl" id="ENST00000542499">
<property type="protein sequence ID" value="ENSP00000445002"/>
<property type="gene ID" value="ENSG00000110243"/>
</dbReference>
<dbReference type="GeneID" id="116519"/>
<dbReference type="KEGG" id="hsa:116519"/>
<dbReference type="UCSC" id="uc001ppr.4">
<property type="organism name" value="human"/>
</dbReference>
<dbReference type="CTD" id="116519"/>
<dbReference type="DisGeNET" id="116519"/>
<dbReference type="EuPathDB" id="HostDB:ENSG00000110243.11"/>
<dbReference type="GeneCards" id="APOA5"/>
<dbReference type="HGNC" id="HGNC:17288">
<property type="gene designation" value="APOA5"/>
</dbReference>
<dbReference type="MalaCards" id="APOA5"/>
<dbReference type="MIM" id="144650">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="145750">
<property type="type" value="phenotype"/>
</dbReference>
<dbReference type="MIM" id="606368">
<property type="type" value="gene"/>
</dbReference>
<dbReference type="neXtProt" id="NX_Q6Q788"/>
<dbReference type="OpenTargets" id="ENSG00000110243"/>
<dbReference type="Orphanet" id="413">
<property type="disease" value="Hyperlipoproteinemia type 4"/>
</dbReference>
<dbReference type="Orphanet" id="70470">
<property type="disease" value="Hyperlipoproteinemia type 5"/>
</dbReference>
<dbReference type="PharmGKB" id="PA24888"/>
<dbReference type="eggNOG" id="ENOG410IKFF">
<property type="taxonomic scope" value="Eukaryota"/>
</dbReference>
<dbReference type="eggNOG" id="ENOG410YHUG">
<property type="taxonomic scope" value="LUCA"/>
</dbReference>
<dbReference type="GeneTree" id="ENSGT00810000125596"/>
<dbReference type="HOGENOM" id="HOG000253942"/>
<dbReference type="HOVERGEN" id="HBG050545"/>
<dbReference type="InParanoid" id="Q6Q788"/>
<dbReference type="KO" id="K09025"/>
<dbReference type="OMA" id="HRSVAPH"/>
<dbReference type="OrthoDB" id="EOG091G0IA5"/>
<dbReference type="PhylomeDB" id="Q6Q788"/>
<dbReference type="TreeFam" id="TF334458"/>
<dbReference type="Reactome" id="R-HSA-1989781">
<property type="pathway name" value="PPARA activates gene expression"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-381426">
<property type="pathway name" value="Regulation of Insulin-like Growth Factor (IGF) transport and uptake by Insulin-like Growth Factor Binding Proteins (IGFBPs)"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8957275">
<property type="pathway name" value="Post-translational protein phosphorylation"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963889">
<property type="pathway name" value="Assembly of active LPL and LIPC lipase complexes"/>
</dbReference>
<dbReference type="Reactome" id="R-HSA-8963901">
<property type="pathway name" value="Chylomicron remodeling"/>
</dbReference>
<dbReference type="SIGNOR" id="Q6Q788"/>
<dbReference type="GeneWiki" id="APOA5"/>
<dbReference type="GenomeRNAi" id="116519"/>
<dbReference type="PRO" id="PR:Q6Q788"/>
<dbReference type="Proteomes" id="UP000005640">
<property type="component" value="Chromosome 11"/>
</dbReference>
<dbReference type="Bgee" id="ENSG00000110243"/>
<dbReference type="CleanEx" id="HS_APOA5"/>
<dbReference type="ExpressionAtlas" id="Q6Q788">
<property type="expression patterns" value="baseline and differential"/>
</dbReference>
<dbReference type="Genevisible" id="Q6Q788">
<property type="organism ID" value="HS"/>
</dbReference>
<dbReference type="GO" id="GO:0072562">
<property type="term" value="C:blood microparticle"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042627">
<property type="term" value="C:chylomicron"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005788">
<property type="term" value="C:endoplasmic reticulum lumen"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0005576">
<property type="term" value="C:extracellular region"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0005615">
<property type="term" value="C:extracellular space"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034364">
<property type="term" value="C:high-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034361">
<property type="term" value="C:very-low-density lipoprotein particle"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0015485">
<property type="term" value="F:cholesterol binding"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0017127">
<property type="term" value="F:cholesterol transporter activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0008047">
<property type="term" value="F:enzyme activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0019899">
<property type="term" value="F:enzyme binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008201">
<property type="term" value="F:heparin binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060229">
<property type="term" value="F:lipase activator activity"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0035473">
<property type="term" value="F:lipase binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0008289">
<property type="term" value="F:lipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0060230">
<property type="term" value="F:lipoprotein lipase activator activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070325">
<property type="term" value="F:lipoprotein particle receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050750">
<property type="term" value="F:low-density lipoprotein particle receptor binding"/>
<property type="evidence" value="ECO:0000353"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0031210">
<property type="term" value="F:phosphatidylcholine binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0060228">
<property type="term" value="F:phosphatidylcholine-sterol O-acyltransferase activator activity"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0005543">
<property type="term" value="F:phospholipid binding"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0055090">
<property type="term" value="P:acylglycerol homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0044267">
<property type="term" value="P:cellular protein metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0006695">
<property type="term" value="P:cholesterol biosynthetic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033344">
<property type="term" value="P:cholesterol efflux"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042632">
<property type="term" value="P:cholesterol homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034380">
<property type="term" value="P:high-density lipoprotein particle assembly"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0006869">
<property type="term" value="P:lipid transport"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0042157">
<property type="term" value="P:lipoprotein metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0031102">
<property type="term" value="P:neuron projection regeneration"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0046470">
<property type="term" value="P:phosphatidylcholine metabolic process"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0033700">
<property type="term" value="P:phospholipid efflux"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0010873">
<property type="term" value="P:positive regulation of cholesterol esterification"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0045723">
<property type="term" value="P:positive regulation of fatty acid biosynthetic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0050996">
<property type="term" value="P:positive regulation of lipid catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0051006">
<property type="term" value="P:positive regulation of lipoprotein lipase activity"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0048260">
<property type="term" value="P:positive regulation of receptor-mediated endocytosis"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010898">
<property type="term" value="P:positive regulation of triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0010902">
<property type="term" value="P:positive regulation of very-low-density lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0043687">
<property type="term" value="P:post-translational protein modification"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0030300">
<property type="term" value="P:regulation of intestinal cholesterol absorption"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0019216">
<property type="term" value="P:regulation of lipid metabolic process"/>
<property type="evidence" value="ECO:0000304"/>
<property type="project" value="Reactome"/>
</dbReference>
<dbReference type="GO" id="GO:0043691">
<property type="term" value="P:reverse cholesterol transport"/>
<property type="evidence" value="ECO:0000318"/>
<property type="project" value="GO_Central"/>
</dbReference>
<dbReference type="GO" id="GO:0042246">
<property type="term" value="P:tissue regeneration"/>
<property type="evidence" value="ECO:0000270"/>
<property type="project" value="UniProtKB"/>
</dbReference>
<dbReference type="GO" id="GO:0019433">
<property type="term" value="P:triglyceride catabolic process"/>
<property type="evidence" value="ECO:0000315"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0070328">
<property type="term" value="P:triglyceride homeostasis"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0006641">
<property type="term" value="P:triglyceride metabolic process"/>
<property type="evidence" value="ECO:0000314"/>
<property type="project" value="BHF-UCL"/>
</dbReference>
<dbReference type="GO" id="GO:0034370">
<property type="term" value="P:triglyceride-rich lipoprotein particle remodeling"/>
<property type="evidence" value="ECO:0000501"/>
<property type="project" value="Ensembl"/>
</dbReference>
<dbReference type="InterPro" id="IPR000074">
<property type="entry name" value="ApoA_E"/>
</dbReference>
<dbReference type="Pfam" id="PF01442">
<property type="entry name" value="Apolipoprotein"/>
<property type="match status" value="2"/>
</dbReference>
<proteinExistence type="evidence at protein level"/>
<keyword id="KW-0162">Chylomicron</keyword>
<keyword id="KW-0175">Coiled coil</keyword>
<keyword id="KW-0181">Complete proteome</keyword>
<keyword id="KW-0225">Disease mutation</keyword>
<keyword id="KW-0345">HDL</keyword>
<keyword id="KW-0445">Lipid transport</keyword>
<keyword id="KW-0597">Phosphoprotein</keyword>
<keyword id="KW-0621">Polymorphism</keyword>
<keyword id="KW-1185">Reference proteome</keyword>
<keyword id="KW-0964">Secreted</keyword>
<keyword id="KW-0732">Signal</keyword>
<keyword id="KW-0813">Transport</keyword>
<keyword id="KW-0850">VLDL</keyword>
<feature type="signal peptide" evidence="3">
<location>
<begin position="1"/>
<end position="23"/>
</location>
</feature>
<feature type="chain" description="Apolipoprotein A-V" id="PRO_0000001981">
<location>
<begin position="24"/>
<end position="366"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="3">
<location>
<begin position="54"/>
<end position="157"/>
</location>
</feature>
<feature type="coiled-coil region" evidence="3">
<location>
<begin position="236"/>
<end position="262"/>
</location>
</feature>
<feature type="modified residue" description="Phosphothreonine; by FAM20C" evidence="16">
<location>
<position position="55"/>
</location>
</feature>
<feature type="modified residue" description="Phosphoserine" evidence="1">
<location>
<position position="59"/>
</location>
</feature>
<feature type="sequence variant" description="In allele APOA5*3; associated with high plasma triglyceride levels; dbSNP:rs3135506." id="VAR_021165" evidence="6 11 12">
<original>S</original>
<variation>W</variation>
<location>
<position position="19"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs34282181." id="VAR_035124">
<original>D</original>
<variation>E</variation>
<location>
<position position="37"/>
</location>
</feature>
<feature type="sequence variant" description="In dbSNP:rs3135507." id="VAR_021166" evidence="12">
<original>V</original>
<variation>M</variation>
<location>
<position position="153"/>
</location>
</feature>
<feature type="sequence variant" description="Associated with high plasma triglyceride levels; dbSNP:rs2075291." id="VAR_021167" evidence="10">
<original>G</original>
<variation>C</variation>
<location>
<position position="185"/>
</location>
</feature>
<evidence key="1" type="ECO:0000244">
<source>
<dbReference type="PubMed" id="24275569"/>
</source>
</evidence>
<evidence key="2" type="ECO:0000250"/>
<evidence key="3" type="ECO:0000255"/>
<evidence key="4" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11577099"/>
</source>
</evidence>
<evidence key="5" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="11588264"/>
</source>
</evidence>
<evidence key="6" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12417524"/>
</source>
</evidence>
<evidence key="7" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12709436"/>
</source>
</evidence>
<evidence key="8" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12810715"/>
</source>
</evidence>
<evidence key="9" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12899628"/>
</source>
</evidence>
<evidence key="10" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12915450"/>
</source>
</evidence>
<evidence key="11" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="12920097"/>
</source>
</evidence>
<evidence key="12" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15108119"/>
</source>
</evidence>
<evidence key="13" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="15528295"/>
</source>
</evidence>
<evidence key="14" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="16200213"/>
</source>
</evidence>
<evidence key="15" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="17997385"/>
</source>
</evidence>
<evidence key="16" type="ECO:0000269">
<source>
<dbReference type="PubMed" id="26091039"/>
</source>
</evidence>
<evidence key="17" type="ECO:0000305"/>
<sequence length="366" mass="41213" checksum="A1C9C207024D0DAF" modified="2004-07-05" version="1" precursor="true">
MASMAAVLTWALALLSAFSATQARKGFWDYFSQTSGDKGRVEQIHQQKMAREPATLKDSL
EQDLNNMNKFLEKLRPLSGSEAPRLPQDPVGMRRQLQEELEEVKARLQPYMAEAHELVGW
NLEGLRQQLKPYTMDLMEQVALRVQELQEQLRVVGEDTKAQLLGGVDEAWALLQGLQSRV
VHHTGRFKELFHPYAESLVSGIGRHVQELHRSVAPHAPASPARLSRCVQVLSRKLTLKAK
ALHARIQQNLDQLREELSRAFAGTGTEEGAGPDPQMLSEEVRQRLQAFRQDTYLQIAAFT
RAIDQETEEVQQQLAPPPPGHSAFAPEFQQTDSGKVLSKLQARLDDLWEDITHSLHDQGH
SHLGDP
</sequence>
</entry>
<copyright>
Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
Distributed under the Creative Commons Attribution-NoDerivs License
</copyright>
</uniprot>